Nucleosome aficionados! Our new review "Nucleosome spacing across cell types, diseases, and ages" is out in NAR: academic.oup.com/nar/article…
A huge effort to pull together what we’ve learned about nucleosome spacing in many systems. Enjoy!
#nucleosomics#nucleosome#chromatin#cfDNA
ALT Figure 1. (A) Classical gel electrophoresis experiments showing mono-, di-, tri-, tetra-, and further multinucleosome bands upon chromatin digestion. (B) The nucleosome repeat length (NRL) is defined as the genomic distance between the centres of two neighbouring nucleosomes.
ALT Figure 2. Nucleosome mapping using MNase-seq versus ATAC-seq. (A) In MNase-seq, nucleosomes in both open and tightly packed genomic regions are accessible to digestion. MNase preferentially cleaves DNA between nucleosomes and digests DNA until it encounters a histone octamer, which provides a footprint of nucleosome-protected DNA regions. (B) Bulk MNase-seq results in averaged maps across millions of cells, effectively capturing all possible nucleosome positioning configurations. (C) Single-cell MNase-seq (scMNase-seq) results in a noisier and sparser signal. The resulting footprints still represent nucleosome-protected regions, but not all nucleosomes are represented. (D) In ATAC-seq, open regions can be accessed by the enzyme Tn5 transposase, which can insert primers in regions free from the binding of nucleosomes and transcription factors (TFs). (E) For open chromatin regions, nucleosome maps can be obtained from ATAC-seq similar to MNase-seq. (F) Closed, tightly packed chromatin...
ALT Figure 5. Molecular mechanisms affecting nucleosome spacing. (A) Linker histones H1 and nonhistone chromatin proteins which compete with H1s and modulate nucleosome spacing through structural and electrostatic mechanisms. (B) Chromatin remodellers actively reposition nucleosomes following context-dependent rules. (C) Cell state-dependent chromatin boundaries formed by CTCF and other structural proteins, as well as associated recruitment of chromatin remodellers which space nucleosomes. (D) Gene activity associated with remodeller action and RNA polymerases transcribing through the nucleosomes, leading to smaller distances between nucleosomes in regulatory regions and gene bodies. (E) DNA sequence repeats of different types.
ALT Figure 6. Examples of NRL changes in biological systems. (A) Cell differentiation leads to NRL changes between different cell types, e.g. mouse dorsal root ganglia neurons (NRL ∼165 bp) versus cortical astrocytes (NRL ∼183 bp) [175]. Schematic cell shapes are adapted from an image created in BioRender (https://BioRender.com/89trj2t). (B) Paired normal versus tumour breast tissues show NRL shortening in cancer (figure adapted from [36] under the CC BY 4.0 licence (https://creativecommons.org/licenses/by/4.0/)). (C) Nucleosome positioning derived from cfDNA of human volunteers shows NRL increase with age (figure reprinted from [79] under the CC BY 4.0 licence (https://creativecommons.org/licenses/by/4.0/)).
Congratulations to Negin Behboodi on successfully passing your PhD viva! We are so proud of you! Keep an eye out for Negin's upcoming big papers! And thank you to the kind examiners @mikhailspivakov and @amarcobio!
ALT Figure 1. (A) Experimental setup investigated (Fakhouri et al
2010). The enhancer element contains two binding sites for
repressor ‘R’ and four for activator ‘A1–A4’. The distance d is
varied. (B) Gene expression as a function of d plotted as 1 – P, with
P being the repressor quenching efficiency reported by Arnosti and
co-workers (Fakhouri et al 2010). (C) A lattice model of the
nucleosome that allows DNA unwrapping with 1 bp resolution (Teif
et al 2010). (D) Activator binding to the leftmost ‘A’ site calculated
as a function of distance d assuming that the contact of nucleosome
‘N’ with repressor is cooperative (w = 1000). Repressor and
activator cover 6 bp upon binding to DNA and exclude each other at
distances < 6 bp. Nucleosomes form nonspecifically, cover up to 147 bp and can partially unwrap with a homogeneous unwrapping potential
Congratulations to Amishasingh Beeharry for successfully passing the MSD viva! You are the best, Amisha! Thank you very much to the examiners, Abdenour Soufi and Toni Marco!
Great to see that this preprint used our software NucTools to calculate NRL, and reached conclusions confirming our previous paper, which reported effect of linker histones H1 on cfDNA fragmentation patterns and nucleosome spacing in cancer tissues/cfDNA link.springer.com/article/10…
ALT Figure 5 from Jacob et al, 2024. NRL shortening as a novel breast cancer marker. A–E) NRL values calculated for each individual sample from this study inside different types of genomic regions. A) Transcriptionally active A-compartments of chromatin annotated in breast cancer MCF-7 cells; B) Regions surrounding gene promoters. C Genomic regions around Alu repeats; D) Regions enriched with H1X linker histones in breast cancer T47D cells; E) Differentially methylated DNA regions annotated based on cell lines MCF-10A, MCF-7 and MDA-MB-231. Open squares—average NRL values for a given condition; horizontal lines—median values. The colours of the points are assigned per sample as in Fig. 3A. F) A scheme of the change of nucleosome compaction in breast cancer tissues. DNA (black) is wrapped around histone octamers (grey) in contact with linker histones (blue). MNase used in this study or apoptotic nucleases present in situ (orange) cut DNA not protected by nucleosomes and linker histones.
Excited to share our latest preprint by Alexis Yang and Gary Lee, in collab with the @jberchuck lab: biorxiv.org/content/10.1101/…. We found that transcription of enhancers (a mark of activation) causes distinct fragmentation patterns in #cfDNA.
Happy to announce that our department (School of Life Sciences at the University of Essex) is upgraded to number 6th out of 91 UK universities in the subject area Biology according to the Guardian University Guide 2026. theguardian.com/education/ng…
Excited to share our latest study published in Nucleic Acids Research: academic.oup.com/nar/article…
It’s the cover story for Issue #12! We drew inspiration from Greek mythology to illustrate CTCF’s constant struggle in shaping the 3D genome architecture.
Excited to share our latest study published in Nucleic Acids Research: academic.oup.com/nar/article…
It’s the cover story for Issue #12! We drew inspiration from Greek mythology to illustrate CTCF’s constant struggle in shaping the 3D genome architecture.
NHS announced that it will start offering first liquid biopsy tests for diagnostics of lung and breast cancer; also planning expansion to pancreatic and gallbladder cancers england.nhs.uk/2025/05/nhs-f…
We have a postdoctoral opening for a researcher with experience in bioinformatics of DNA sequencing and machine learning to work on the development of new methods for cancer diagnostics related to nucleosomes, chromatin and more jobs.ac.uk/job/DMK060/senior…. Apply by 21st April 2025!
Very happy to contribute to this paper about cfDNA in SCLC, led by the team of Anish Thomas. It's already online in Genome Medicine:
Takahashi et al., Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor genomemedicine.biomedcentral…
Early detection of #PancreaticCancer saves lives.
@TeifLab@EssexLifeSci are using cutting-edge technology to measure fragments of tumour DNA in the blood.
This "liquid biopsy" could provide an accurate & affordable new test for pancreatic cancer: bit.ly/3F3vXF1
ALT Dr Vladimir Teif and his team at the University of Essex
2nd time at #FOG2025 (1st time presenting!), it never disappoints!✨
Great talks, groundbreaking research and good times with old&new friends
Huge thanks to everyone who stopped by my poster, truly grateful for the interest & discussions
Already looking forward to next year!🙌
We're pleased to share that @isabella_ciu (PhD Student, University of Essex) will be sharing her research in the #FOG2025 Poster Zone! Register now: hubs.la/Q032Q75f0
Encouraging news to start the new year: NHS reports 2.7% improvement in early cancer diagnostics in comparison to pre-pandemic levels. An estimated additional 7,000 patients diagnosed at an early stage.
Latest NHS data shows that the proportion of patients being diagnosed with cancer at an early stage in England has risen to its highest ever level.
Find out more about the latest data.
➡️ england.nhs.uk/2025/01/early…
ALT Early cancer diagnosis reaches highest ever level. A woman is receiving a breast screening from a healthcare worker.
Interestingly, the BBC coverage attributed this success to NHS testing vans stationed in busy areas where any person can walk-in without referral. Probably technological genomics developments also contributed to this improvement, in any case these are set to help going forward
Happy New Year! 2024 was not easy, but despite many challenges we also achieved a lot. We've got grants, published papers, have new exciting findings. This would not be possible without support of friends and collaborators. Wishing you health, happiness, peace & success in 2025!